Phase 1, Febuxostat XR Relative Bioavailability Study
NCT02504320
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Febuxostat XR 80 mg Capsule F1
DRUG:
Febuxostat XR 80 mg Capsule F2
DRUG:
Febuxostat XR 80 mg Capsule F3
DRUG:
Febuxostat XR 80 mg Capsule F4
Sponsor
Takeda